86.22.Z - Specialist medical practice activities
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
47.7 - Retail sale of other goods in specialised stores
55.10.Z - Hotels and similar accommodation
68.20.Z - Rental and operating of own or leased real estate
70.22.Z - Business and other management consultancy activities
72.19.Z - Other research and experimental development on natural sciences and engineering
77.29.Z - Rental and leasing of other personal and household goods
85.59.B - Other out-of-school forms of education, not elsewhere classified
86 - Human health activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,9 | 0,8 | 0,6 | -21,2 |
Gross profit (loss) | 0,9 | 0,8 | 0,6 | -23,4 |
EBITDA | 1,1 | 1 | 0,6 | -35,9 |
Short time liabilities | 0,8 | 0,7 | 0,5 | -29,1 |
Other operating costs | 0 | 0 | 0,2 | 37 430,8 |
Equity capital | 1,8 | 1,6 | 1,5 | -10,8 |
Operating profit (EBIT) | 0,9 | 0,8 | 0,6 | -27,7 |
Assets | 2,6 | 2,6 | 2,1 | -20,5 |
Net profit (loss) | 0,8 | 0,7 | 0,5 | -24,4 |
Cash | 1,7 | 1,7 | 1,4 | -17,3 |
Net income from sale | 4,7 | 4,8 | 5,1 | 6,9 |
Liabilities and provisions for liabilities | 0,8 | 1 | 0,6 | -36,1 |
Working assets | 2 | 2 | 1,7 | -15,6 |
Other income costs | 0 | 0 | 0,1 | 289 322,8 |
Depreciation | 0,2 | 0,2 | 0 | -73 |
% | % | % | p.p. | |
Profitability of capital | 48 | 44,2 | 37,5 | -6,7 |
Equity capital to total assets | 67,6 | 61,6 | 69,1 | 7,5 |
Gross profit margin | 19,7 | 16,7 | 12 | -4,7 |
EBITDA Margin | 24 | 20,3 | 12,2 | -8,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 65 | 55 | 36 | -19 |
Current financial liquidity indicator | 2.337693214416504 | 2.8243255615234375 | 3.360199213027954 | 0,6 |
Net dept to EBITDA | -1.5133413076400757 | -1.455045223236084 | -2.052875518798828 | -0,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane